Charts suggest the stage is getting set for a year-end rally in the S&P 500, CNBC’s Jim Cramer said Wednesday, leaning on analysis from technician Mark Sebastian. “The charts, as interpreted by Mark...
Toyota Motor Corp has halted production at two factories in Japan due to a supply shortage, a spokesperson told Reuters on Thursday. The stoppage means that Toyota cannot return to normal operations in December as it...
Apple CEO Tim Cook reportedly “personally lobbied officials” for concessions that would allow the company to do business in China. Apple CEO Tim Cook reportedly “personally lobbied officials” for...
As a value investor, Warren Buffett loves to buy quality assets on the cheap. But there’s one beaten-down asset he won’t be picking up anytime soon: Bitcoin. The price of the world’s largest cryptocurrency dropped more...
U.S. stock futures pointed to a second day of gains on Tuesday, as investors focus on the latest news on the omicron variant of coronavirus. What’s happening Futures on the Dow Jones Industrial Average rose 297 points...
The metaverse will be disruptive to society once it gains its true form over the next decade Jefferies analyst Simon Powell argues. But several companies could be poised to benefit greatly from the new digital ecosystem...
A year ago, the average stock strategist may not have seen that the world’s best-performing index in 2021 would be Mongolia, or that a movie theater chain would rise 13-fold. Most Read from Bloomberg The Hot New Trend...
With valuations still sky-high by historical standards, some investors might be hesitant to buy into the stock market. And understandably so. But according to CNBC’s Jim Cramer, there are still opportunities for those...
Stocks wobble after a roller-coaster week dominated by Omicron concerns; Didi officially delists from the NYSE; D.C. shutdown averted; Elon Musk’s Tesla share-sale spree surpasses $10 billion; and back to the economy:...
Investing in biotech stocks isn’t for the faint of heart. There can be significant volatility and risk. However, putting some portion of your portfolio in biotechs holds the potential to pay off nicely over the...